carboxymethylated dextran biosensor chips (cm5) (Biacore)
90
Structured Review
Biacore
carboxymethylated dextran biosensor chips (cm5)
Carboxymethylated Dextran Biosensor Chips (Cm5), supplied by Biacore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biosensor+chip+cm5/biacore+3000+instrument/us12364736-917-2-6
Average 90 stars, based on 1 article reviews
Carboxymethylated Dextran Biosensor Chips (Cm5), supplied by Biacore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/biosensor+chip+cm5/biacore+3000+instrument/us12364736-917-2-6
Average 90 stars, based on 1 article reviews
carboxymethylated dextran biosensor chips (cm5) - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Methods for treating heterotopic ossification Article Snippet: Such techniques include ELISAs, Article Title: ALK7 binding proteins and uses thereof Article Snippet: In particular embodiments, the variant ALK7-binding protein has at least one characteristic selected from: (a) decreases the formation of a complex containing ALK7, a type II receptor (e.g., ActRIIA or ActRIIB), and one or more TGF-beta superfamily ligands (e.g., activin B, activin AB, Nodal, GDF1, GDF3 and/or GDF8) on the surface of cells expressing ALK7 and the ActRII receptor in the presence of the one or more TGF-beta superfamily ligands; (b) competes with one or more type II receptors for binding to ALK7; (c) competes with one or more TGF-beta superfamily ligands (e.g., activin B, activin AB, Nodal, GDF1, GDF3 and/or GDF8) for binding to ALK7; (d) decreases the phosphorylation of ALK7 in cells expressing ALK7 and a type II receptor (e.g., ActRIIA or ActRIIB) in the presence of one or more TGF-beta super family ligands (e.g., GDF1, GDF3, GDF8, activin B, activin AB, and/or Nodal); (e) decreases the phosphorylation of Smads (e.g., Smad2 and/or Smad3) in cells expressing ALK7 and a type II receptor (e.g., ActRIIA and/or ActRIIB) in the presence of one or more TGF-beta ligands (e.g., GDF1, GDF3, GDF8, activin B, activin AB, and/or Nodal); (f) binds to Article Title: ALK7 binding proteins and uses thereof Article Snippet: In some embodiments, an ALK7-binding protein binds to Binding Assay:Article Title: ALK7 binding proteins and uses thereof Article Snippet: The BIACORE® assay described above is an exemplary assay used to determine if two ALK7-binding proteins such as anti-ALK7 antibodies compete with/block each other for binding ALK7. .. On rare occasions, particular ALK7-binding proteins may not bind to ALK7-Fc coupled via anti-Fc IgG to a Article Title: Anti-CD40 antibodies and uses thereof Article Snippet: 5.4 Quantitative Analysis of NK003 Dynamics and Affinity by Surface Plasmon Resonance Biacore T200 (GE Healthcare) was used to detect the affinity of the antibodies NK003, NK004. .. Data processing was performed using Article Title: ALK7 binding proteins and uses thereof Article Snippet: .. Likewise, known assays are available for readily selecting anti-ALK7-antibodies displaying desirable features (e.g., assays for determining binding affinity to ALK7; cross-blocking assays such as the BIACORE®-based human ALK7-binding SPR Assay:Article Title: NKp46 binding agents Article Snippet: .. Competition and Affinity Study by Surface Plasmon Resonance (SPR) Biacore T100 General Procedure and Reagents SPR measurements were performed on a Article Title: Antibodies binding to phospho-tau comprising phosphorylated Ser396 and Ser404 and methods of detecting thereof Article Snippet: In accordance with the present invention, the antibody-based molecule of the present invention binds to its Tau epitope with an affinity corresponding to a KD of about 10−7 M or less, such as about 10−8 M or less, such as about 10−9 M or less when determined by, for instance, surface plasmon resonance (SPR) technology in a Biacore 3000 instrument (preferably using the antibody as the ligand and the antigen as the analyte). .. In accordance with the present invention, the antibody-based molecule of the present invention binds to its Tau epitope with an affinity corresponding to a KD of about 10−7 M or less, such as about 10−8 M or less, such as about 10−9 M or less when determined by, for instance, surface plasmon resonance (SPR) technology in a Software:Article Title: Anti-CD40 antibodies and uses thereof Article Snippet: 5.4 Quantitative Analysis of NK003 Dynamics and Affinity by Surface Plasmon Resonance Biacore T200 (GE Healthcare) was used to detect the affinity of the antibodies NK003, NK004. .. Data processing was performed using |